J2778 Ranibizumab injection
Also known as: ranibizumab, lucentis, susvimo
Injection of ranibizumab (Lucentis, Susvimo), a recombinant humanized monoclonal antibody fragment against vascular endothelial growth factor A (VEGF-A) for retinal diseases.
In Plain Language
eye injection for macular degeneration
Clinical Context
Administered by intravitreal injection for age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion.
RVU Information
CPT J2778 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J2778?
CPT J2778 (Ranibizumab injection) is a J Codes (Drugs) code. Injection of ranibizumab (Lucentis, Susvimo), a recombinant humanized monoclonal antibody fragment against vascular endothelial growth factor A (VEGF-A) for retinal diseases.
How is J2778 administered?
CPT J2778 is administered by a healthcare provider, typically via injection or infusion. Administered by intravitreal injection for age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion. It is used by Ophthalmology, Retina.
When is CPT J2778 used?
Administered by intravitreal injection for age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.